AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $128,000 | -30.8% | 17,092 | -15.8% | 0.00% | -42.9% |
| Q1 2022 | $185,000 | +60.9% | 20,310 | +23.5% | 0.01% | +75.0% |
| Q4 2021 | $115,000 | -40.4% | 16,441 | -3.0% | 0.00% | -42.9% |
| Q3 2021 | $193,000 | -37.9% | 16,944 | -2.5% | 0.01% | -41.7% |
| Q1 2021 | $311,000 | -21.3% | 17,385 | -40.5% | 0.01% | -29.4% |
| Q4 2020 | $395,000 | +20.4% | 29,240 | +4.8% | 0.02% | +6.2% |
| Q3 2020 | $328,000 | +91.8% | 27,908 | +141.2% | 0.02% | +77.8% |
| Q2 2020 | $171,000 | – | 11,572 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |